Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002434 · ClinicalTrials.gov registry record · NA
A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
A NA study, sponsored by U.S. Bioscience.
- Completed
- Registry status
- NA
- Development phase
NCT00002434: Completed NA study, sponsored by U.S. Bioscience.
NCT00002434 is a NA study that has completed, run by U.S. Bioscience. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002434, a NA study, has completed, sponsored by U.S. Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have demonstrated severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or parenteral pentamidine).
Interventions
- DRUG Leucovorin calcium
- DRUG Trimetrexate glucuronate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002434 record still lists
NCT00002434 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Leucovorin calcium is the first listed.
NCT00002434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002434 about?
NCT00002434 is a clinical study titled "A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)". To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have demonstrated severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or parenteral pentamidine).
What is the current status of trial NCT00002434?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002434?
The interventions under investigation include: Leucovorin calcium (DRUG), Trimetrexate glucuronate (DRUG).
Who is sponsoring clinical trial NCT00002434?
This trial is sponsored by U.S. Bioscience, which has 5 total clinical trials registered on ClinicalTrials.gov.